Replies to post #246562 on Biotech Values

[DewDiligence]

$ENTA is getting $200M cash and the *worst-case* scenario involves forgoing the NPV of $84M in royalties spread over 10yr, which is $60M or so (depending on your discount rate). In short, I like the deal. https://t.co/Wsu9cuA5j1

— Roy Friedman (@DewDiligence) April 25, 2023